SIGHT SCIENCES, INC. Accrued Liabilities and Other Liabilities
SIGHT SCIENCES, INC. (SGHT) had Accrued Liabilities and Other Liabilities of $3.81 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-05
- 2026-06-30: Accrued Liabilities and Other Liabilities $3.81M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $9.19M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $3.61M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $3.90M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2026-06-30 | $3.81M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $9.19M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $3.61M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $3.90M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.63M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.23M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.10M 10-K · filed 2026-03-04 |
| 2024-09-30 | $4.61M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.97M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $6.00M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $3.77M 10-K · filed 2025-03-07 |
| 2022-12-31 | $7.78M 10-K · filed 2024-03-13 |
| 2021-12-31 | $4.17M 10-K · filed 2023-03-16 |
| 2020-12-31 | $3.09M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |